1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Medicine 1.2.3 Hemodialysis 1.2.4 Peritoneal Dialysis 1.2.5 Kidney Transplantation 1.3 Market by Application 1.3.1 Global Chronic Kidney Disease (CKD) Treatment Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospitals 1.3.3 Kidney Dialysis Centers 1.3.4 At Homes 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Chronic Kidney Disease (CKD) Treatment Market Perspective (2018-2029) 2.2 Chronic Kidney Disease (CKD) Treatment Growth Trends by Region 2.2.1 Global Chronic Kidney Disease (CKD) Treatment Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Chronic Kidney Disease (CKD) Treatment Historic Market Size by Region (2018-2023) 2.2.3 Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Region (2024-2029) 2.3 Chronic Kidney Disease (CKD) Treatment Market Dynamics 2.3.1 Chronic Kidney Disease (CKD) Treatment Industry Trends 2.3.2 Chronic Kidney Disease (CKD) Treatment Market Drivers 2.3.3 Chronic Kidney Disease (CKD) Treatment Market Challenges 2.3.4 Chronic Kidney Disease (CKD) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Chronic Kidney Disease (CKD) Treatment Players by Revenue 3.1.1 Global Top Chronic Kidney Disease (CKD) Treatment Players by Revenue (2018-2023) 3.1.2 Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Players (2018-2023) 3.2 Global Chronic Kidney Disease (CKD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Chronic Kidney Disease (CKD) Treatment Revenue 3.4 Global Chronic Kidney Disease (CKD) Treatment Market Concentration Ratio 3.4.1 Global Chronic Kidney Disease (CKD) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Chronic Kidney Disease (CKD) Treatment Revenue in 2022 3.5 Chronic Kidney Disease (CKD) Treatment Key Players Head office and Area Served 3.6 Key Players Chronic Kidney Disease (CKD) Treatment Product Solution and Service 3.7 Date of Enter into Chronic Kidney Disease (CKD) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Chronic Kidney Disease (CKD) Treatment Breakdown Data by Type 4.1 Global Chronic Kidney Disease (CKD) Treatment Historic Market Size by Type (2018-2023) 4.2 Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Type (2024-2029) 5 Chronic Kidney Disease (CKD) Treatment Breakdown Data by Application 5.1 Global Chronic Kidney Disease (CKD) Treatment Historic Market Size by Application (2018-2023) 5.2 Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Chronic Kidney Disease (CKD) Treatment Market Size (2018-2029) 6.2 North America Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2018-2023) 6.4 North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Chronic Kidney Disease (CKD) Treatment Market Size (2018-2029) 7.2 Europe Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2018-2023) 7.4 Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size (2018-2029) 8.2 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2018-2023) 8.4 Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Chronic Kidney Disease (CKD) Treatment Market Size (2018-2029) 9.2 Latin America Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2018-2023) 9.4 Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size (2018-2029) 10.2 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2018-2023) 10.4 Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Fresenius 11.1.1 Fresenius Company Detail 11.1.2 Fresenius Business Overview 11.1.3 Fresenius Chronic Kidney Disease (CKD) Treatment Introduction 11.1.4 Fresenius Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.1.5 Fresenius Recent Development 11.2 DaVita 11.2.1 DaVita Company Detail 11.2.2 DaVita Business Overview 11.2.3 DaVita Chronic Kidney Disease (CKD) Treatment Introduction 11.2.4 DaVita Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.2.5 DaVita Recent Development 11.3 Baxter 11.3.1 Baxter Company Detail 11.3.2 Baxter Business Overview 11.3.3 Baxter Chronic Kidney Disease (CKD) Treatment Introduction 11.3.4 Baxter Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.3.5 Baxter Recent Development 11.4 Nipro 11.4.1 Nipro Company Detail 11.4.2 Nipro Business Overview 11.4.3 Nipro Chronic Kidney Disease (CKD) Treatment Introduction 11.4.4 Nipro Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.4.5 Nipro Recent Development 11.5 B. Braun 11.5.1 B. Braun Company Detail 11.5.2 B. Braun Business Overview 11.5.3 B. Braun Chronic Kidney Disease (CKD) Treatment Introduction 11.5.4 B. Braun Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.5.5 B. Braun Recent Development 11.6 Asahi Kasei 11.6.1 Asahi Kasei Company Detail 11.6.2 Asahi Kasei Business Overview 11.6.3 Asahi Kasei Chronic Kidney Disease (CKD) Treatment Introduction 11.6.4 Asahi Kasei Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.6.5 Asahi Kasei Recent Development 11.7 Nikkiso 11.7.1 Nikkiso Company Detail 11.7.2 Nikkiso Business Overview 11.7.3 Nikkiso Chronic Kidney Disease (CKD) Treatment Introduction 11.7.4 Nikkiso Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.7.5 Nikkiso Recent Development 11.8 WEGO 11.8.1 WEGO Company Detail 11.8.2 WEGO Business Overview 11.8.3 WEGO Chronic Kidney Disease (CKD) Treatment Introduction 11.8.4 WEGO Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.8.5 WEGO Recent Development 11.9 Newsol 11.9.1 Newsol Company Detail 11.9.2 Newsol Business Overview 11.9.3 Newsol Chronic Kidney Disease (CKD) Treatment Introduction 11.9.4 Newsol Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.9.5 Newsol Recent Development 11.10 Mayo Clinic 11.10.1 Mayo Clinic Company Detail 11.10.2 Mayo Clinic Business Overview 11.10.3 Mayo Clinic Chronic Kidney Disease (CKD) Treatment Introduction 11.10.4 Mayo Clinic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.10.5 Mayo Clinic Recent Development 11.11 Guangdong Biolight 11.11.1 Guangdong Biolight Company Detail 11.11.2 Guangdong Biolight Business Overview 11.11.3 Guangdong Biolight Chronic Kidney Disease (CKD) Treatment Introduction 11.11.4 Guangdong Biolight Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.11.5 Guangdong Biolight Recent Development 11.12 Medtronic 11.12.1 Medtronic Company Detail 11.12.2 Medtronic Business Overview 11.12.3 Medtronic Chronic Kidney Disease (CKD) Treatment Introduction 11.12.4 Medtronic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.12.5 Medtronic Recent Development 11.13 Sanxin Medtec 11.13.1 Sanxin Medtec Company Detail 11.13.2 Sanxin Medtec Business Overview 11.13.3 Sanxin Medtec Chronic Kidney Disease (CKD) Treatment Introduction 11.13.4 Sanxin Medtec Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.13.5 Sanxin Medtec Recent Development 11.14 Jafron Biomedical 11.14.1 Jafron Biomedical Company Detail 11.14.2 Jafron Biomedical Business Overview 11.14.3 Jafron Biomedical Chronic Kidney Disease (CKD) Treatment Introduction 11.14.4 Jafron Biomedical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.14.5 Jafron Biomedical Recent Development 11.15 SWS Hemodialysis Care 11.15.1 SWS Hemodialysis Care Company Detail 11.15.2 SWS Hemodialysis Care Business Overview 11.15.3 SWS Hemodialysis Care Chronic Kidney Disease (CKD) Treatment Introduction 11.15.4 SWS Hemodialysis Care Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.15.5 SWS Hemodialysis Care Recent Development 11.16 Tianyi Medical 11.16.1 Tianyi Medical Company Detail 11.16.2 Tianyi Medical Business Overview 11.16.3 Tianyi Medical Chronic Kidney Disease (CKD) Treatment Introduction 11.16.4 Tianyi Medical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.16.5 Tianyi Medical Recent Development 11.17 AstraZeneca 11.17.1 AstraZeneca Company Detail 11.17.2 AstraZeneca Business Overview 11.17.3 AstraZeneca Chronic Kidney Disease (CKD) Treatment Introduction 11.17.4 AstraZeneca Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.17.5 AstraZeneca Recent Development 11.18 Vifor Pharma 11.18.1 Vifor Pharma Company Detail 11.18.2 Vifor Pharma Business Overview 11.18.3 Vifor Pharma Chronic Kidney Disease (CKD) Treatment Introduction 11.18.4 Vifor Pharma Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) 11.18.5 Vifor Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Medicine Table 3. Key Players of Hemodialysis Table 4. Key Players of Peritoneal Dialysis Table 5. Key Players of Kidney Transplantation Table 6. Global Chronic Kidney Disease (CKD) Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Chronic Kidney Disease (CKD) Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Chronic Kidney Disease (CKD) Treatment Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region (2018-2023) Table 10. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region (2024-2029) Table 12. Chronic Kidney Disease (CKD) Treatment Market Trends Table 13. Chronic Kidney Disease (CKD) Treatment Market Drivers Table 14. Chronic Kidney Disease (CKD) Treatment Market Challenges Table 15. Chronic Kidney Disease (CKD) Treatment Market Restraints Table 16. Global Chronic Kidney Disease (CKD) Treatment Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Chronic Kidney Disease (CKD) Treatment Market Share by Players (2018-2023) Table 18. Global Top Chronic Kidney Disease (CKD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Treatment as of 2022) Table 19. Ranking of Global Top Chronic Kidney Disease (CKD) Treatment Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Chronic Kidney Disease (CKD) Treatment Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Chronic Kidney Disease (CKD) Treatment Product Solution and Service Table 23. Date of Enter into Chronic Kidney Disease (CKD) Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Chronic Kidney Disease (CKD) Treatment Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Type (2018-2023) Table 27. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Type (2024-2029) Table 29. Global Chronic Kidney Disease (CKD) Treatment Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Application (2018-2023) Table 31. Global Chronic Kidney Disease (CKD) Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Chronic Kidney Disease (CKD) Treatment Revenue Market Share by Application (2024-2029) Table 33. North America Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Chronic Kidney Disease (CKD) Treatment Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Chronic Kidney Disease (CKD) Treatment Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size by Country (2024-2029) & (US$ Million) Table 48. Fresenius Company Detail Table 49. Fresenius Business Overview Table 50. Fresenius Chronic Kidney Disease (CKD) Treatment Product Table 51. Fresenius Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 52. Fresenius Recent Development Table 53. DaVita Company Detail Table 54. DaVita Business Overview Table 55. DaVita Chronic Kidney Disease (CKD) Treatment Product Table 56. DaVita Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 57. DaVita Recent Development Table 58. Baxter Company Detail Table 59. Baxter Business Overview Table 60. Baxter Chronic Kidney Disease (CKD) Treatment Product Table 61. Baxter Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 62. Baxter Recent Development Table 63. Nipro Company Detail Table 64. Nipro Business Overview Table 65. Nipro Chronic Kidney Disease (CKD) Treatment Product Table 66. Nipro Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 67. Nipro Recent Development Table 68. B. Braun Company Detail Table 69. B. Braun Business Overview Table 70. B. Braun Chronic Kidney Disease (CKD) Treatment Product Table 71. B. Braun Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 72. B. Braun Recent Development Table 73. Asahi Kasei Company Detail Table 74. Asahi Kasei Business Overview Table 75. Asahi Kasei Chronic Kidney Disease (CKD) Treatment Product Table 76. Asahi Kasei Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 77. Asahi Kasei Recent Development Table 78. Nikkiso Company Detail Table 79. Nikkiso Business Overview Table 80. Nikkiso Chronic Kidney Disease (CKD) Treatment Product Table 81. Nikkiso Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 82. Nikkiso Recent Development Table 83. WEGO Company Detail Table 84. WEGO Business Overview Table 85. WEGO Chronic Kidney Disease (CKD) Treatment Product Table 86. WEGO Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 87. WEGO Recent Development Table 88. Newsol Company Detail Table 89. Newsol Business Overview Table 90. Newsol Chronic Kidney Disease (CKD) Treatment Product Table 91. Newsol Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 92. Newsol Recent Development Table 93. Mayo Clinic Company Detail Table 94. Mayo Clinic Business Overview Table 95. Mayo Clinic Chronic Kidney Disease (CKD) Treatment Product Table 96. Mayo Clinic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 97. Mayo Clinic Recent Development Table 98. Guangdong Biolight Company Detail Table 99. Guangdong Biolight Business Overview Table 100. Guangdong Biolight Chronic Kidney Disease (CKD) Treatment Product Table 101. Guangdong Biolight Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 102. Guangdong Biolight Recent Development Table 103. Medtronic Company Detail Table 104. Medtronic Business Overview Table 105. Medtronic Chronic Kidney Disease (CKD) Treatment Product Table 106. Medtronic Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 107. Medtronic Recent Development Table 108. Sanxin Medtec Company Detail Table 109. Sanxin Medtec Business Overview Table 110. Sanxin Medtec Chronic Kidney Disease (CKD) Treatment Product Table 111. Sanxin Medtec Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 112. Sanxin Medtec Recent Development Table 113. Jafron Biomedical Company Detail Table 114. Jafron Biomedical Business Overview Table 115. Jafron Biomedical Chronic Kidney Disease (CKD) Treatment Product Table 116. Jafron Biomedical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 117. Jafron Biomedical Recent Development Table 118. SWS Hemodialysis Care Company Detail Table 119. SWS Hemodialysis Care Business Overview Table 120. SWS Hemodialysis Care Chronic Kidney Disease (CKD) Treatment Product Table 121. SWS Hemodialysis Care Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 122. SWS Hemodialysis Care Recent Development Table 123. Tianyi Medical Company Detail Table 124. Tianyi Medical Business Overview Table 125. Tianyi Medical Chronic Kidney Disease (CKD) Treatment Product Table 126. Tianyi Medical Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 127. Tianyi Medical Recent Development Table 128. AstraZeneca Company Detail Table 129. AstraZeneca Business Overview Table 130. AstraZeneca Chronic Kidney Disease (CKD) Treatment Product Table 131. AstraZeneca Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 132. AstraZeneca Recent Development Table 133. Vifor Pharma Company Detail Table 134. Vifor Pharma Business Overview Table 135. Vifor Pharma Chronic Kidney Disease (CKD) Treatment Product Table 136. Vifor Pharma Revenue in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) & (US$ Million) Table 137. Vifor Pharma Recent Development Table 138. Research Programs/Design for This Report Table 139. Key Data Information from Secondary Sources Table 140. Key Data Information from Primary Sources List of Figures Figure 1. Global Chronic Kidney Disease (CKD) Treatment Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Chronic Kidney Disease (CKD) Treatment Market Share by Type: 2022 VS 2029 Figure 3. Medicine Features Figure 4. Hemodialysis Features Figure 5. Peritoneal Dialysis Features Figure 6. Kidney Transplantation Features Figure 7. Global Chronic Kidney Disease (CKD) Treatment Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Chronic Kidney Disease (CKD) Treatment Market Share by Application: 2022 VS 2029 Figure 9. Hospitals Case Studies Figure 10. Kidney Dialysis Centers Case Studies Figure 11. At Homes Case Studies Figure 12. Others Case Studies Figure 13. Chronic Kidney Disease (CKD) Treatment Report Years Considered Figure 14. Global Chronic Kidney Disease (CKD) Treatment Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 15. Global Chronic Kidney Disease (CKD) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 16. Global Chronic Kidney Disease (CKD) Treatment Market Share by Region: 2022 VS 2029 Figure 17. Global Chronic Kidney Disease (CKD) Treatment Market Share by Players in 2022 Figure 18. Global Top Chronic Kidney Disease (CKD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Treatment as of 2022) Figure 19. The Top 10 and 5 Players Market Share by Chronic Kidney Disease (CKD) Treatment Revenue in 2022 Figure 20. North America Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. North America Chronic Kidney Disease (CKD) Treatment Market Share by Country (2018-2029) Figure 22. United States Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Canada Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Europe Chronic Kidney Disease (CKD) Treatment Market Share by Country (2018-2029) Figure 26. Germany Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. France Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. U.K. Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Italy Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Russia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Nordic Countries Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Asia-Pacific Chronic Kidney Disease (CKD) Treatment Market Share by Region (2018-2029) Figure 34. China Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Japan Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. South Korea Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Southeast Asia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. India Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Australia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Latin America Chronic Kidney Disease (CKD) Treatment Market Share by Country (2018-2029) Figure 42. Mexico Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Brazil Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East & Africa Chronic Kidney Disease (CKD) Treatment Market Share by Country (2018-2029) Figure 46. Turkey Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Saudi Arabia Chronic Kidney Disease (CKD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Fresenius Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 49. DaVita Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 50. Baxter Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 51. Nipro Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 52. B. Braun Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 53. Asahi Kasei Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 54. Nikkiso Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 55. WEGO Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 56. Newsol Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 57. Mayo Clinic Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 58. Guangdong Biolight Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 59. Medtronic Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 60. Sanxin Medtec Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 61. Jafron Biomedical Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 62. SWS Hemodialysis Care Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 63. Tianyi Medical Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 64. AstraZeneca Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 65. Vifor Pharma Revenue Growth Rate in Chronic Kidney Disease (CKD) Treatment Business (2018-2023) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Fresenius DaVita Baxter Nipro B. Braun Asahi Kasei Nikkiso WEGO Newsol Mayo Clinic Guangdong Biolight Medtronic Sanxin Medtec Jafron Biomedical SWS Hemodialysis Care Tianyi Medical AstraZeneca Vifor Pharma